Land This Deal Even Lower Than Director Robbins Did
March 20, 2023 at 10:24 AM EDT
There's an old saying on Wall Street about insider buying: there are many possible reasons to sell a stock, but only one reason to buy. Back on March 14, RAPT Therapeutics Inc's Director, Wendye Robbins, invested $97,612.00 into 5,000 shares of RAPT, for a cost per share of $19.52..